regeneron | Pharmatell

Eyes on Pharma

Check-out What Intel Caught our Eye

Nov 174 min read

Eyes on Sanofi, Regeneron, Novo Nordisk, and Pfizer

We've had Eyes On some of the recent deals, results, and investor actions. Check out the happenings at Sanofi/Opella, Pfizer, Regeneron, and

Sep 205 min read

Eyes on BioPharma Headlines

This month, we've had Eyes on investment trends, strategic restructuring, and FDA decisions. Fall seems to be gearing up, and we can't wait

Feb 83 min read

Eyes on BioPharma Portfolio Strategies

This week we've had Eyes how BioPharma are bolstering their Portfolios for long-term success. From licensing assets ...

Dec 1, 20233 min read

Eyes on Clinical Trial Data, Supply Upgrades, and Patent Litigation

The news this week was full of "Ups-n-Downs." We've noted a few here and know there were more surprises with clinical data results, M&A, and